Randomized Controlled Trial
Copyright ©The Author(s) 2021.
World J Gastroenterol. Jan 7, 2021; 27(1): 107-128
Published online Jan 7, 2021. doi: 10.3748/wjg.v27.i1.107
Table 5 Fecal characteristic (volume, type, color, odor, pH) and defecation frequency

Group
Baseline period
Ingestion period
P value
VolumeProbiotic-treated2.20 ± 0.792.23 ± 0.960.861
Placebo2.37 ± 0.952.29 ± 0.900.232
TypeProbiotic-treated3.59 ± 0.933.22 ± 1.170.081
Placebo4.02 ± 1.143.89 ± 0.930.342
ColorProbiotic-treated1.86 ± 0.571.73 ± 0.550.201
Placebo2.00 ± 0.591.95 ± 0.540.701
OdorProbiotic-treated1.11 ± 0.371.10 ± 0.280.932
Placebo1.26 ± 0.351.32 ± 0.410.572
pHProbiotic-treated5.72 ± 0.315.76 ± 0.280.513
Placebo5.58 ± 0.405.75 ± 0.340.073
Defecation frequency4Probiotic-treated12.93 ± 3.6113.40 ± 4.520.582
Placebo14.67 ± 4.9315.70 ± 7.570.512

  • Citation: Rahayu ES, Mariyatun M, Putri Manurung NE, Hasan PN, Therdtatha P, Mishima R, Komalasari H, Mahfuzah NA, Pamungkaningtyas FH, Yoga WK, Nurfiana DA, Liwan SY, Juffrie M, Nugroho AE, Utami T. Effect of probiotic Lactobacillus plantarum Dad-13 powder consumption on the gut microbiota and intestinal health of overweight adults. World J Gastroenterol 2021; 27(1): 107-128
  • URL: https://www.wjgnet.com/1007-9327/full/v27/i1/107.htm
  • DOI: https://dx.doi.org/10.3748/wjg.v27.i1.107